Source: Annual Congress 2010 - Colonisation and infection in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Badawy, L. Mohamed, A. Fathy (Egypt). Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection. Eur Respir J 2010; 36: Suppl. 54, 2889

Member's Comments

No comment yet.

Related content which might interest you: Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Inflammatory changes, recovery and recurrence at COPD exacerbation Source: Eur Respir J 2007; 29: 527-534 Year: 2007 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002 IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Eosinopenia as a prognostic factor in patients with acute exacerbation of chronic obstructive pulmonary disease. Source: International Congress 2017 – COPD and weaning Year: 2017 Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Inflammatory biomarkers as outcome predictors of acute respiratory failure on top of chronic obstructive pulmonary diseases (COPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011